In late 2019, the emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused an outbreak of viral pneumonia (COVID-19) in Wuhan, China. Italy was the first Western Country hit by the SARS-CoV-2 devastating pandemic back in early 2020.
ViroStatics promptly decided to leverage its decades of experience in drug combinations. Five drugs have been identified, synergizing with each other. One of these combinations is under preclinical testing, planning to start clinical trials in a very short term.